Answer:HIPAA Violations
Explanation:Ethically and legally this impedes my work because it can put the patient in danger as well as others if personal information is found out and disclosed. It can literally ruin a person and the fines are massive for breaches. It has happened to me before and I had to report a coworker to the board for it, so that my license was not impacted. They announced personal test results in the lobby and not in a private room.
The answer to this question is true
The original weight is 4.
Explanation:
20%= 1/5 if u don’t know the percentage then u can simply by doing..
20/100 then u divide it. U can do this by any other numbers such as 2, 4,5,10 and 20. U can do which ever way u like but i would recommend doing it either by 10 or 20.
So if we divide it by 20 we do...
20/100 divided by 20= 1/5
Or
20/100 divided by 10= 2/10
2/10 divided by 2 = 1/5
You can see the bigger the number that fits in is faster, although u can do it any way u feel like doing.
So we have got 1/5 from 20%. Now we do...
1/5 divided by 20. So when we do this, we use the bottom number to divide it and the top number to times it.
So..
1/5 u could use as 20 divided by 5..
Then 1 times the number that u get from ur before sum.
The answer is 4.
Because 1/5= 20 divided by 5 = 4
Since we have a 1 left we do..
4 times 1 which is... 4.
( u don’t need to show these parts in doing ur working, but i am doing these so they can help u understand)
So the answer is 4 and is the original weight.
I hope this is clear and helps u! :D
Answer:
Missing drug list. Inbox me please. Thank you
Explanation:
Answer:
b) blastic red blood cell (RBC).
Explanation:
In excess of 340 blood group antigens have now been described that vary between individuals. Thus, any unit of blood that is nonautologous represents a significant dose of alloantigen. Most blood group antigens are proteins, which differ by a single amino acid between donors and recipients. Approximately 1 out of every 70 individuals are transfused each year (in the United States alone), which leads to antibody responses to red blood cell <u>(RBC) alloantigens</u> in some transfusion recipients. When alloantibodies are formed, in many cases, RBCs expressing the antigen in question can no longer be safely transfused. However, despite chronic transfusion, only 3% to 10% of recipients (in general) mount an alloantibody response. In some disease states, rates of alloimmunization are much higher (eg, sickle cell disease). For patients who become alloimmunized to multiple antigens, ongoing transfusion therapy becomes increasingly difficult or, in some cases, impossible. While alloantibodies are the ultimate immune effector of humoral alloimmunization, the cellular underpinnings of the immune system that lead to ultimate alloantibody production are complex, including antigen consumption, antigen processing, antigen presentation, T-cell biology.
